P2D Bioscience Receives NIH Funding to Develop Drugs for Lung Disease CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Jul 19, 2011) - P2D Bioscience (P2D, Inc.), a pharmaceutical development company, announced today that the company has received a $320,000 grant from...